C. R. Bard (Murray Hill, New Jersey) reported FDA approval of the Lutonix 035 Drug Coated Balloon (DCB) catheter for percutaneous transluminal angioplasty (PTA), after pre-dilatation, for the treatment of de novo or restenotic lesions up to 150mm in length in native vascular disease of the superficial femoral or popliteal arteries with reference vessel diameters of 4-6mm. Read More
